Harrow (HROW) Change in Receivables (2014 - 2026)

Harrow's (HROW) quarterly Change in Receivables came in at -$9.8 million in Q1 2026, up 74.92% year-on-year from -$5.6 million in Q1 2025, and down 129.6% quarter-over-quarter from $33.2 million in Q4 2025.

Harrow (HROW) Change in Receivables (2014 - 2026) Analysis & Trends

Harrow's Change in Receivables history runs 13 years deep, the most recent figure standing at -$9.8 million for Q1 2026.

  • On a quarterly basis, Change in Receivables rose 74.92% year-over-year to -$9.8 million in Q1 2026; TTM through Mar 2026 was $24.4 million, a 50.73% decrease from a year earlier, with the FY2025 full-year figure at -$5.0 million, down 106.24% from the prior year.
  • Change in Receivables eased to -$9.8 million in Q1 2026 per HROW's latest filing, from $33.2 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $62.8 million in Q4 2024 and bottomed at -$39.2 million in Q1 2025.
  • The 5-year median for Change in Receivables is $1.5 million (2022), against an average of $5.7 million.
  • Across the five-year window, Change in Receivables surged 5080.0% in 2023 and sank 366.84% in 2025, its largest moves.
  • Year by year, Change in Receivables stood at -$449000.0 in 2022, then surged by 4121.6% to $18.1 million in 2023, then jumped by 247.67% to $62.8 million in 2024, then slumped by 47.09% to $33.2 million in 2025, then plunged by 129.6% to -$9.8 million in 2026.
  • Per Business Quant, the three latest HROW Change in Receivables figures stand at -$9.8 million (Q1 2026), $33.2 million (Q4 2025), and -$1.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -78.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 106.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -621.82 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -38.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 126.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 81.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Harrow 1.56 Bn 1.47 Bn 27.05 Mn -9.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.83 Mn
Mar 31, 2026 -9.83 Mn
Dec 31, 2025 33.22 Mn
Dec 31, 2025 33.22 Mn
Sep 30, 2025 -1.01 Mn
Sep 30, 2025 -1.01 Mn
Jun 30, 2025 1.99 Mn
Jun 30, 2025 1.99 Mn
Mar 31, 2025 -39.20 Mn
Mar 31, 2025 -39.20 Mn
Dec 31, 2024 62.78 Mn
Dec 31, 2024 62.78 Mn
Sep 30, 2024 1.82 Mn
Sep 30, 2024 1.82 Mn
Jun 30, 2024 24.03 Mn
Jun 30, 2024 24.03 Mn
Mar 31, 2024 -8.40 Mn
Mar 31, 2024 -8.40 Mn
Dec 31, 2023 18.06 Mn
Dec 31, 2023 18.06 Mn